Microchip Technology: Trust Platform Design Suite Accelerates Embedded Security Implementations While Adding Ecosystem for Third-Party Contributions

New Delhi, May 19, 2021 — In 2019, Microchip Technology released its Trust Platform for its CryptoAuthentication™ family, bringing the industry’s first pre-provisioned solutions for hardware-based secure elements to companies of all sizes that want an easy way to implement secure authentication. 

Today, the company is further enhancing this service with the latest enhancements to its Trust Platform Design Suite (TPDS) — its dedicated software platform for device configuration and onboarding to Microchip secure provisioning services for embedded security.

TPDS version 2 (v2) software now enables Microchip partners to add use cases to its rich security solutions onboarding ecosystem, further expanding developers’ already broad options for implementing best-in-class security. It also now includes support for additional security solutions such as the TA100, the first cryptographic companion device for the automotive market.

Pricing and Availability:

Microchip’s open-source Trust Platform Design Suite is available for download on Microchip’s website at no cost for Trust&GO and TrustFLEX flows. The site also allows access to training videos, interactive application notes, C code and other project support. TrustCUSTOM software extensions for TPDS are available under NDA and can be purchased through Microchip’s purchasing portal at $20.00 each.

For additional information, contact a Microchip sales representative, authorized worldwide distributor or visit Microchip’s website.

****

Popular posts from this blog

Rotary Utsav 2026 District Conference Inaugurated with Celebration of Service, Leadership & Unity

Navin’s Housing Showcases Key Projects & Exclusive Offers at FAIRPRO 2026

IPMA Global Project Profession Forum 2026 Inaugurated at Mahabalipuram; Focus on AI, Innovation & Sustainable Transformation

Revivo Clinic Launched in Chennai – A New Hope for Obesity & Diabetes Patients

Apollo Cancer Centre & Apollo Proton Cancer Centre Launch ‘ZERO TO HERO’ Campaign to Champion Stage Zero Cancer Detection